The Effect of Co-infection of Food-Borne Pathogenic Bacteria on the Progression of Infection in Mice
Overview
Affiliations
is a well-known food-borne pathogen that causes human gastroenteritis. Food products that contain may also be contaminated by other pathogens, however, whether this multiple contamination leads to more severe infection remains unclear. In this study, mice were gavaged with and other food-borne pathogenic bacteria to mimic a multiple infection. It was demonstrated that the load was elevated when the mice were co-infected with and , and the campylobacteriosis that followed was also enhanced, with features of decreased body weight, heavier bloody stools and more pronounced inflammatory changes to the colon. In addition, infection with was also promoted by co-infection with entero-invasive but unaffected over time. In contrast to and entero-invasive , co-infection by showed little effect on infection and even hindered its progress. In addition, the intestinal microecology was also affected by co-infection of with other pathogens, with an increased relative abundance of unclassified Enterobacteriaceae, decreased levels of butyric acid and changes in the abundance of several genera of gut microbe, which suggests that some food-borne pathogenic bacteria might affect the progression of infection in mice by influencing the composition of the gut microbiota and the resulting changes in SCFA levels. Collectively, our findings suggest that co-infection of with other pathogenic bacteria can impact on the progression of infection by in mice, which may also have implication for the etiology of on human health.
Antagonistic Effects of Actin-Specific Toxins on Typhimurium Invasion into Mammalian Cells.
Heisler D, Kudryashova E, Hitt R, Williams B, Dziejman M, Gunn J Biomolecules. 2024; 14(11).
PMID: 39595604 PMC: 11591686. DOI: 10.3390/biom14111428.
Antagonistic effects of actin-specific toxins on Typhimurium invasion into mammalian cells.
Heisler D, Kudryashova E, Hitt R, Williams B, Dziejman M, Gunn J bioRxiv. 2024; .
PMID: 39005411 PMC: 11245040. DOI: 10.1101/2024.07.01.601609.
Chagneau S, Gaucher M, Theriault W, Fravalo P, Thibodeau A Front Microbiol. 2023; 13:1071175.
PMID: 36817113 PMC: 9937062. DOI: 10.3389/fmicb.2022.1071175.
Wang Y, He Y, Liang Y, Liu H, Chen X, Kulyar M Microb Cell Fact. 2023; 22(1):30.
PMID: 36803386 PMC: 9936653. DOI: 10.1186/s12934-023-02027-z.
and its metabolites play key roles in the treatment of campylobacteriosis in mice.
Jiang L, Yuan C, Ye W, Huang Q, Chen Z, Wu W Front Immunol. 2023; 13:1061627.
PMID: 36713373 PMC: 9877526. DOI: 10.3389/fimmu.2022.1061627.